Invited Seminars

2000 Mississippi State University, Jackson Arizona State University, Department of Chemistry, Phoenix Washington University, Department of Chemistry, St. Louis Institute for Cancer Research, London, England National Cancer Institute, Bethesda, Maryland University of Arizona, Department of Biochemistry and Biophysics, Tucson 2001 University of Virginia, Department of Chemistry, Charlottesville University of Pittsburgh, School of Pharmacy Southwestern Medical Center, Department of Pharmacology, Dallas, Texas China Pharmaceutical University, Nanjing, China Purdue University Cancer Center, Lafayette, Indiana University of Nottingham, Pharmaceutical Sciences Department, England University of Arkansas Cancer Center, Little Rock Symposium Presentations 2000 Invited speaker for Sixth International Symposium on Biological Reactive Intermediates, "Structural basis for the differential repair of Et 743–DNA adducts," Paris, France (July) Invited speaker for American Chemical Society symposium entitled Physical Chemistry of Nucleic Acids: In Memory of Matt Petersheim, "G-quadruplexes and associated gene targets for drug design," Washington, D.C. (August) Invited speaker for British Pharmaceutical Conference, "Telomere maintenance mechanism as a target for drug action," Birmingham (September) Symposium Chair and invited speaker for ACS Pacifichem meeting. Session: Nucleic Acid–Protein Complexes as Drug Receptors. "G-quadruplexes and associated gene targets for drug design," Honolulu (December) Consultant at NCI, Application of Structural Biology in Cancer (December) 2001 Invited speaker for 2nd PharmaMar Symposium on marine Compounds: Novel Mechanisms of Action in Cancer Research. "Et 743–DNA adducts: A structural basis for sequence-dependent UvrABC repair recognition and incision," Madrid, Spain (January) Invited speaker at AACR meeting. Sunrise Session, "Secondary DNA structures as targets for cancer therapeutics," New Orleans (March) Invited plenary speaker at NACON V meeting. "G-quadruplexes and associated gene targets for drug design," Sheffield, England (April) Speaker for Arizona Cancer Drug Development meeting. "Et 743–DNA adducts: A structural basis for sequence-dependent UvrABC repair recognition and incision," Scottsdale, Arizona (April) Consultant for National Foundation for Cancer Research, Beijing, China (May) External Review Board member of Cancer Center, Purdue University (May) Invited speaker at Bioorganic Gordon Research Conference. "G-quadruplexes and associated gene targets for drug design," Andover, New Hampshire (June) Frank Rose Memorial Lecture speaker for British Cancer Research Meeting. "DNA and associated oncogene targets for cancer therapeutics," Leeds, England (July) Invited speaker for Biochemistry Society Meeting, Symposium on Apoptosis and DNA Damage. "Secondary DNA structures as targets for cancer therapeutics," Dublin, Ireland (July) Invited speaker at Cancer Therapeutics Gordon Research Conference. "Unusual DNA structures as targets for selective therapeutics," New London, New Hampshire (July) Invited speaker at Symposium honoring Phil Portoghese, Minneapolis (August) Chairperson and speaker at National Foundation for Cancer Research meeting, Washington, D.C. (September) Invited speaker at Arizona Cancer Center Workshop, Tucson (September) Flinn Foundation presentation (November)

Comments to Webmaster, Last Updated: July 2, 2002
All contents copyright © 2002. Laurence H. Hurley, Ph.D.

1515 North Campbell Avenue
Room 4949
Tucson, Arizona 85724
Phone: 520 626-5621